Company / R&D per Share
ClearPoint Neuro, Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.50
FY2025
5-year range
$0.46 / $0.54
FY2021-FY2025
Trend
+5.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 10 years, ranging from $0.22 in FY2018 to $1.15 in FY2016.
Based on SEC 10-K filings.
0.50 in FY2025 with a 5-year CAGR of +10.3%.
Improved from $0.48 to $0.50 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +3.0%
- 5-Year CAGR
- +10.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share increased 5.9% year-over-year.
- Peak r&d per share was recorded in FY2016.
- Lowest r&d per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.71 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.50 | +5.9% |
| FY2024 | $0.47 | -0.3% |
| FY2023 | $0.48 | +3.5% |
| FY2022 | $0.46 | -15.4% |
| FY2021 | $0.54 | +77.0% |
| FY2020 | $0.31 | +20.6% |
| FY2019 | $0.26 | +18.1% |
| FY2018 | $0.22 | -72.2% |
| FY2017 | $0.78 | -32.5% |
| FY2016 | $1.15 | +4298.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026